Supplementary Figure S1 from Impact of Biomarker-Matched Therapies on Outcomes in Patients with Sarcoma Enrolled in Early-Phase Clinical Trials (SAMBA 101)
<p>Treemap of most common drug mechanisms for patients treated in biomarker-matched studies.</p>
Saved in:
Similar Items
-
SPIRIT schedule of enrollment, interventions, and assessment.
by: Kim Christin Honselmann (21176936)
Published: (2025) -
Participant timeline: Schedule of enrollment, interventions, and assessments.
by: Pierre Angelvy (22683450)
Published: (2025) -
A table showing the clinical participants who were enrolled in a further or higher education course and their research activity and self-declared involvement.
by: Zoe Edwards (3823528)
Published: (2025) -
Supplementary Figure S1 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases
by: James S. Wilmott (15008931)
Published: (2025) -
Supplementary Tables S1-7 from Clinical Features Associated with Outcomes and Biomarker Analysis of Dabrafenib plus Trametinib Treatment in Patients with BRAF-Mutant Melanoma Brain Metastases
by: James S. Wilmott (15008931)
Published: (2025)